![](https://investorshub.advfn.com/uicon/113775.png?cb=1640546002)
Tuesday, October 03, 2017 3:05:08 PM
Management appears to have been very busy. Here's a rough list:
https://clinicaltrials.gov/ct2/results?term=cellceutix
ph2b prurisol Psoriasis trial, first received on clinicaltrials.gov on 10.14.16
ph2a kevetrin Ovarian Cancer trial, first received on clinicaltrials.gov on 2.1.17
and, a ph2 PoC brilacidin IBD: UC (UP/UPS) trial outside the US. Results can be seen here: http://www.ipharminc.com/press-release/2017/7/13/innovation-pharmaceuticals-phase-2-poc-trial-for-inflammatory-bowel-disease-achieves-induction-of-remission-in-a-majority-of-patients-treated-with-brilacidin
The brilacidin ph2 Oral Mucositis trial gave interim results on 3.27.17 http://www.ipharminc.com/press-release/2017/3/27/cellceutix-reports-very-encouraging-interim-analysis-of-phase-2-drug-candidate-brilacidin-for-severe-oral-mucositis-om-in-head-and-neck-cancer-patients-high-potential-for-preventative-treatment
Anticipated upcoming events with my timeline guestimate:
My expectations are for the brilacidin ph2 Oral Mucositis trial to give topline results in late Oct or mid Nov 2017.
My expectations for topline results on the prurisol ph2b Psoriasis trial are anticipated for around Dec 2017.
The kevetrin ph2a Ovarian Cancer trial may give some sort of readout in Dec 2017.
In Reply to 'MXAMDUD' first ihub post on this board:
Another day of horrific price action. these bums should defend their stock by actually buying it in the open market
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM